Physician profile
Frederick J Piwko
NPI 1639196421
$923.14
in general payments reported to CMS, 2019-2025
16 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.43 · 2022: $12.29 · 2023: $13.39 · 2024: $307 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $182.47 | 2024-2025 | Trelegy Ellipta, Bexsero, Shingrix |
| Novo Nordisk INC | $178.74 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.79 | 2024-2025 | Jardiance, Synjardy |
| Pfizer INC. | $82.85 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $74.30 | 2019-2025 | Breztri, Farxiga |
| Lilly USA, LLC | $61.37 | 2024-2025 | Mounjaro, Jardiance, Zepbound |
| Exact Sciences Corporation | $42.95 | 2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $36.52 | 2025 | Korlym |
| Dexcom, INC. | $26.58 | 2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $24.44 | 2025 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $24.01 | 2025 | Voquezna |
| Seqirus USA INC | $18.74 | 2019 | |
| Merck Sharp & Dohme LLC | $15.41 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.29 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.39 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Piwko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.